Atlas Trials

A Revised Tafenoquine Dose to Improve Radical Cure for Vivax Malaria

Clinical trial NCT06148792 · RECRUITING

Trial details

NCT number
NCT06148792
Sponsor
Menzies School of Health Research
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Vivax Malaria
Start date
2024-05-10
Primary completion
2027-03-01
Enrollment
1090

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.